A Review on the Evidence Base on the Management of Malaria

Authors

  • Shabani . CT Institute of pharmaceutical sciences
  • Savita Kumari

Abstract

Malaria has been one of the most important infectious diseases of humans for millennia. An estimated 3.3 billion people approximately one-half of the world’s population living in 109 countries—are at risk of contracting this serious and of ten life-threatening diseases. In India the National Malaria Eradication Programme (NMEP), started in 1956, achieved near complete disappearance of the disease in 1960s (from 75 million in 1950s to 0.1 million in 1960s). Malaria accounts for ∼250 million clinical cases and nearly 1 million deaths each year, the great majority of which occur in children younger than 5 years of age and in young, pregnant women. Due to the high specificity of P. falciparum, P. vivax, P. ovale, P. malariae, P. knowlesi to the human host and to the fact that clinical studies in human are not always feasible, our knowledge about this syndrome mainly comes from autopsy studies which can only give us a limited view this deadly syndrome. The current study showed that traditional knowledge is still playing an important role in the treatment of malaria. A well-developed treatment regimen including the artemisinins as a potent antimalarial and other safety preventive measures have played a major role in reducing global burden of malaria over the years. About 54% of the medicinal plants in the survey have been reported as an anti-malarial plant in the literature search. The current review focuses on clinical drug candidates with activity against more than one stages of the malarial parasite life cycle.

 

Keywords: Malaria, millennia; Plasmodium, National malaria eradication programme, artemisinins antimalarial therapy.

Cite this article

Shabani, Savita Kumari. A Review on the Evidence Base on the Management of Malaria. Research & Reviews: A Journal of Pharmacology. 2019; 9(1): 1–11p.

Downloads

Additional Files

Published

2019-06-01

Issue

Vol. 9 No. 1 (2019)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.